REPROCELL USA Launches Advanced GMP Facility for Stem Cell Manufacturing

REPRECELL logo

REPROCELL USA has marked a significant milestone with the inauguration of its state-of-the-art GMP manufacturing facility dedicated to producing high-quality stem cells. This facility, located in Beltsville, Maryland, was officially opened on May 15, 2024, by Mr. Kevin Anderson, Secretary of the Department of Commerce, State of Maryland. The new facility is designed to manufacture […]

New York Blood Center Expands GMP Cell & Gene Therapy Manufacturing in Louisville

New York Blood Center Enterprises logo

New York Blood Center Enterprises (NYBCe) has announced the grand opening of its new GMP facility in Louisville, Kentucky. This state-of-the-art site, part of Comprehensive Cell Solutions (CCS), enhances cell and gene therapy manufacturing capabilities, offering end-to-end services from cell sourcing to cryopreservation and GMP manufacturing. The Louisville facility includes apheresis suites, cleanrooms, and quality […]

Immorta Bio Inc. Announces Breakthrough in Liver Failure Treatment with Stem Cell Technology

image of a liver surrounded by stem cells

Immorta Bio Inc., a company focused on longevity and regenerative medicine, has announced a significant breakthrough in the treatment of liver failure. The company is developing personalized stem cell technologies that show great promise in combating various diseases of aging. Immorta Bio’s research pipeline includes Personalized Regenerative Cells (PRCs), Personalized Mesenchymal Stem Cells (pMSCs), and […]

Theradaptive Secures Landmark Funding to Propel Human Clinical Trials in Stem Cell Research

Theradaptive logo

In a groundbreaking development for stem cell research and regenerative medicine, Theradaptive has secured significant funding from the Maryland Stem Cell Research Fund (MSCRF). This crucial financial boost will support the advancement of their innovative human clinical trials, marking a significant milestone in the field of biotechnology. Theradaptive, a pioneering biopharmaceutical company, is renowned for […]

Revolutionary Stem Cell Technology Trials Could Cure Paralysis

Australian researchers ready for human trials to cure paralysis with stem cells

Queensland researchers believe a cure for paralysis is within reach. The team’s ground-breaking therapy involves taking cells from the patient’s nose and transplanting them into the spinal cord of the same patient. This revolutionary stem cell technology is ready for human trials. Visit Perry Cross Spinal Research Foundation for more info.

Aspen Neuroscience Secures CIRM Grant for Groundbreaking Parkinson’s Disease Stem Cell Therapy

Aspen Neuroscience Logo

In a significant stride towards combating Parkinson’s disease, Aspen Neuroscience has been awarded a prestigious CLIN2 grant by the California Institute for Regenerative Medicine (CIRM). This milestone funding will accelerate the development of their innovative stem cell therapy, ANPD001. Aspen Neuroscience’s proprietary approach leverages cutting-edge induced pluripotent stem cells (iPSCs) to create personalized therapies aimed […]

Maryland Awards $15.4 Million to Boost Stem Cell Research for Cures

Maryland Stem Cell Research Fund

The Maryland Stem Cell Research Commission has just announced a $15.4 million investment aimed at accelerating stem cell research and its applications in developing cures. This significant funding demonstrates Maryland’s commitment to advancing innovative medical research and supporting groundbreaking stem cell therapies. Accelerating Medical Breakthroughs The awards are part of a concerted effort to stimulate […]

Exploring the Frontier of Stem Cell Technology: Century Therapeutics’ Latest Breakthroughs at ASGCT 2024

Century Therapeutics Logo

Century Therapeutics is making significant strides in the field of stem cell therapy, particularly with their induced pluripotent stem cell (iPSC) technology, which was showcased at the 2024 ASGCT Annual Meeting. The company presented compelling preclinical data, emphasizing advancements in treating autoimmune diseases and enhancing the survivability of allogeneic cell therapies against natural killer (NK) […]